Symbol="VYGR"
AssetType="Common Stock"
Name="Voyager Therapeutics Inc"
Description="Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1640266"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="75 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="395303000"
EBITDA="97851000"
PERatio="4.09"
PEGRatio="0"
BookValue="4.995"
DividendPerShare="0"
DividendYield="0"
EPS="2.22"
RevenuePerShareTTM="4.89"
ProfitMargin="0.519"
OperatingMarginTTM="0.49"
ReturnOnAssetsTTM="0.208"
ReturnOnEquityTTM="0.676"
RevenueTTM="190729000"
GrossProfitTTM="-19857000"
DilutedEPSTTM="2.22"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="227.69"
AnalystTargetPrice="13.67"
TrailingPE="4.09"
ForwardPE="-"
PriceToSalesRatioTTM="3.271"
PriceToBookRatio="2.825"
EVToRevenue="1.667"
EVToEBITDA="-8.56"
Beta="1.087"
num_52WeekHigh="14.34"
num_52WeekLow="4.77"
num_50DayMovingAverage="11.51"
num_200DayMovingAverage="8.09"
SharesOutstanding="43535600"
DividendDate="None"
ExDividendDate="None"
symbol="VYGR"
open="9.25"
high="9.25"
low="8.96"
price="9.02"
volume="301561.00"
latest_trading_day="2023-07-20"
previous_close="9.19"
change="-0.17"
change_percent="-1.8498%"
aroon_positive_momentum_days="77"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="77"
Volume_recent_avg="532328"
Change_recent_avg="0.01"
Delta_recent_avg="0.61"
Variance_recent_avg="0.31"
Change_ratio_recent_avg="0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="77"
Aroon_momentum_negative="23"
image_negative_thumbnail_id_1="105"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0071.jpeg"
image_negative_thumbnail_id_2="104"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0072.jpeg"
image_neutral_thumbnail_id_1="592"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_neutral_thumbnail_id_2="571"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_positive_thumbnail_id_1="976"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_positive_thumbnail_id_2="975"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
